Main menu

Responsibility

Medical & Academic Partnerships

Medical & Academic Partnerships

Since its inception in 1984, The Pfizer Medical & Academic Partnerships (MAP) Program has supported the career development of doctors, nurses, pharmacists, and researchers who dedicate their lives to providing direct patient care and/or conducting clinical or epidemiologic research in the hope of improving healthcare and quality of life. Pfizer has proudly funded more than 1,000 research and medical education endeavors.

Regrettably, Pfizer’s External Medical Affairs made the difficult decision to suspend the MAP Fellowship and Visiting Professorship programs.

Pfizer remains committed to supporting and advancing research, innovation, and medical education for academic centers and schools of medicine, nursing, osteopathic medicine, pharmacy, and public health. Through Public-Private Partnerships, Pfizer continues to MAP-a-course of discovery for a wide variety of clinical and population health issues, with the goal of finding innovative ways to promote healthy lifestyles and prevent and treat acute and chronic disease. Partnerships with organizations such as the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) help develop future medical leaders and drive advances in patient care.

Academic institutions and other organizations seeking funding should visit the following page on this website:

Thank you for your understanding. If you have questions or need any additional information about these changes, please feel free to contact us.